Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Avecho Biotechnology Limited
  6. News
  7. Summary
    AVE   AU0000047441

AVECHO BIOTECHNOLOGY LIMITED

(AVE)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about AVECHO BIOTECHNOLOGY LIMITED
01/09AVECHO BIOTECHNOLOGY : Application for quotation of securities - AVE
PU
2021Avecho Biotechnology Enters Licensing, Supply Deal With US Cannabidiol Company
MT
2021Avecho Biotechnology Limited Secures Product License and Supply Agreement with Medterra..
CI
2021Avecho Biotechnology Completes Phase 1 Trial Results for CBD Soft-Gel Product
MT
2021Avecho Biotechnology Limited Releases Results for Its Australian Phase I PK Study Chara..
CI
2021AVECHO BIOTECHNOLOGY : Ties Up with Academic Institution for Osteoarthritis Study
MT
2021Avecho Biotechnology Limited Announces Collaboration with the Lambert Initiative
CI
2021AVECHO BIOTECHNOLOGY : Begins Dosing Volunteers for Phase 1 Cannabidiol Clinical Trial
MT
2021Avecho Biotechnology Limited Announces Dosing Commences for Phase I Human Clinical Tria..
CI
2021AVECHO BIOTECHNOLOGY : Begins Enrolment for Phase 1 Cannabidiol Absorption Trial
MT
2021Avecho Commences Enrolment for Phase I Human Clinical Trial Measuring CBD Absorption
CI
2021Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, ..
CI
2021Avecho Biotechnology to Discuss Cannabidiol Soft-Gel Product with Drug Regulator; Share..
MT
2021AVECHO BIOTECHNOLOGY : Completes Cannabidiol Soft Gel Product Design; Shares Rally 13%
MT
2021Avecho Biotechnology Limited Completes Pharmaceutical CBD Soft-Gel Product
CI
More most relevant news
All news about AVECHO BIOTECHNOLOGY LIMITED
01/09AVECHO BIOTECHNOLOGY : Application for quotation of securities - AVE
PU
2021Avecho Biotechnology Enters Licensing, Supply Deal With US Cannabidiol Company
MT
2021Avecho Biotechnology Limited Secures Product License and Supply Agreement with Medterra..
CI
2021Avecho Biotechnology Completes Phase 1 Trial Results for CBD Soft-Gel Product
MT
2021Avecho Biotechnology Limited Releases Results for Its Australian Phase I PK Study Chara..
CI
2021AVECHO BIOTECHNOLOGY : Ties Up with Academic Institution for Osteoarthritis Study
MT
2021Avecho Biotechnology Limited Announces Collaboration with the Lambert Initiative
CI
2021AVECHO BIOTECHNOLOGY : Begins Dosing Volunteers for Phase 1 Cannabidiol Clinical Trial
MT
2021Avecho Biotechnology Limited Announces Dosing Commences for Phase I Human Clinical Tria..
CI
2021AVECHO BIOTECHNOLOGY : Begins Enrolment for Phase 1 Cannabidiol Absorption Trial
MT
More news
News in other languages on AVECHO BIOTECHNOLOGY LIMITED
2021Avecho Biotechnology achève les résultats de l'essai de phase 1 pour le produit CBD Sof..
2021Avecho Biotechnology s'associe à une institution académique pour une étude sur l'arthro..
2021Avecho Biotechnology commence à doser les volontaires pour l'essai clinique de phase 1 ..
2021Avecho Biotechnology discutera du produit de gel mou de cannabidiol avec l'organisme de..
2021Avecho Biotechnology achève la conception d'un gel mou à base de cannabidiol ; les acti..
2020Avecho Biotechnology entame une étude observationnelle sur la formulation du cannabidio..
2020L'anesthésique d'Avecho Biotechnology passe le test toxicologique ; les actions font un..
More news
Press releases
01/09AVECHO BIOTECHNOLOGY : Application for quotation of securities - AVE
PU
More press releases
Upcoming event on AVECHO BIOTECHNOLOGY LIMITED